
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [NKTR] Nektar Therapeutics
Data updated 2025-Jul-11 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Jul-11 Friday
Open | $24.82 | High | $26.29 +5.92% |
---|---|---|---|
Close | $25.01 | Low | $23.86 -3.87% |
Volume | 1.21 Million 0.67x | Volatility | 10.18% |
Change |
$-0.09
-0.36%
|
Streak | ↓ 1 days -0.36% |
20d SMA | $19.57 +27.8% | 50d SMA | $14.05 +78.0% | 100d SMA | $12.75 +96.2% | 200d SMA | $14.55 +71.9% |
RSI | 66 | MACD | 0.06 | ADX | 43.5 | Stochastic Oscillator | 55.7 53.4 |
CCI | 48.1 | ATR | 2.98 | OBV | 54.9 Million | Chaikin A/D | 813 Thousand |
Market Cap | 244 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 2.8 | Price/Book (mrq) | 1.86 | EV/Revenue (ttm) | 0.65 | EV/EBITDA (ttm) | -0.24 |
% Held by Insiders | 0.82% | % Held by Institutions | 67.25% | Shares Short | 2.51 M | Shares Short (prior month) | 2.45 M |
Short Ratio | 0.93 | Short % of Outstanding | 1.37% | Short % of Float | 1.54% | Shares Short Change (mom) | +2.4% |
Revenue/Share (ttm) | $0.47 | Profit Margin (ttm) | 0.00% | Operating Margin (ttm) | -128.37% | EBITDA (ttm) | -127 M |
Diluted EPS (ttm) | $-1.45 | Current Ratio (mrq) | 6.45 | Return on Assets (ttm) | -15.25% | Return on Equity (ttm) | -110.95% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 8.50% | Operating Cash Flow (ttm) | -193 M | Free Cash Flow (ttm) | -63.6 M | |
Choose view type
Daily Performance for Nektar Therapeutics. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Nektar Therapeutics up to close of 2025-Jul-11 at $25.01
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+1.01%
|
-4.9%
|
+14.4%
|
20.2%
|
+4.5%
|
|
0.67x
|
02 Trailing 10-days
|
|
-15.73%
|
-14.5%
|
+14.4%
|
33.8%
|
+1.6%
|
|
0.44x
|
03 Trailing 20-days
|
|
+161.88%
|
-33.1%
|
+213.0%
|
367.8%
|
+27.8%
|
|
2.35x
|
04 Trailing 30-days
|
|
+138.43%
|
-33.1%
|
+213.0%
|
367.8%
|
+50.8%
|
|
1.63x
|
05 Trailing 50-days
|
|
+125.10%
|
-33.1%
|
+213.0%
|
367.8%
|
+78.0%
|
|
1.87x
|
06 Trailing 100-days
|
|
+69.69%
|
-33.1%
|
+286.0%
|
476.9%
|
+96.2%
|
|
1.79x
|
07 Trailing 200-days
|
|
+28.26%
|
-33.1%
|
+286.0%
|
476.9%
|
+71.9%
|
|
1.22x
|
08 Month-to-date
|
|
-3.21%
|
-5.9%
|
+14.4%
|
21.6%
|
|
|
|
09 Quarter-to-date
|
|
-3.21%
|
-5.9%
|
+14.4%
|
21.6%
|
|
|
|
10 Year-to-date
|
|
+79.28%
|
-33.1%
|
+286.0%
|
476.9%
|
|
|
|
11 Trailing 52-weeks
|
|
+22.60%
|
-33.1%
|
+286.0%
|
476.9%
|
|
|
|
1-year Performance Benchmarks for Nektar Therapeutics:
Related to Nektar Therapeutics
Information for Nektar Therapeutics
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-11 on Google
SEC Reports : Quarterly reports around 2025-Jul-11 on SEC Edgar
Compare Nektar Therapeutics with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Nektar Therapeutics
Industry : Pharmaceuticals industry performance which includes Nektar Therapeutics